HCSGD entry for CD36
1. General information
Official gene symbol | CD36 |
---|---|
Entrez ID | 948 |
Gene full name | CD36 molecule (thrombospondin receptor) |
Other gene symbols | BDPLT10 CHDS7 FAT GP3B GP4 GPIV PASIV SCARB3 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000122 | Negative regulation of transcription from RNA polymerase II promoter | IEA | biological_process |
GO:0001954 | Positive regulation of cell-matrix adhesion | IDA | biological_process |
GO:0002224 | Toll-like receptor signaling pathway | TAS | biological_process |
GO:0002474 | Antigen processing and presentation of peptide antigen via MHC class I | TAS | biological_process |
GO:0002479 | Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | TAS | biological_process |
GO:0002576 | Platelet degranulation | TAS | biological_process |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | TAS | biological_process |
GO:0005041 | Low-density lipoprotein receptor activity | IEA IMP TAS | molecular_function |
GO:0005794 | Golgi apparatus | IEA | cellular_component |
GO:0005886 | Plasma membrane | IDA TAS | cellular_component |
GO:0005887 | Integral component of plasma membrane | TAS | cellular_component |
GO:0006629 | Lipid metabolic process | NAS | biological_process |
GO:0006898 | Receptor-mediated endocytosis | IMP TAS | biological_process |
GO:0006910 | Phagocytosis, recognition | IEA | biological_process |
GO:0007155 | Cell adhesion | IEA | biological_process |
GO:0007166 | Cell surface receptor signaling pathway | IEA | biological_process |
GO:0007263 | Nitric oxide mediated signal transduction | IDA | biological_process |
GO:0007596 | Blood coagulation | TAS | biological_process |
GO:0008035 | High-density lipoprotein particle binding | IEA | molecular_function |
GO:0008289 | Lipid binding | IDA | molecular_function |
GO:0009897 | External side of plasma membrane | IEA | cellular_component |
GO:0009986 | Cell surface | IDA ISS | cellular_component |
GO:0010744 | Positive regulation of macrophage derived foam cell differentiation | IEA IMP | biological_process |
GO:0010886 | Positive regulation of cholesterol storage | IEA | biological_process |
GO:0015911 | Plasma membrane long-chain fatty acid transport | IDA | biological_process |
GO:0016020 | Membrane | TAS | cellular_component |
GO:0016021 | Integral component of membrane | IEA | cellular_component |
GO:0019915 | Lipid storage | IEA IMP | biological_process |
GO:0019934 | CGMP-mediated signaling | IDA | biological_process |
GO:0030168 | Platelet activation | TAS | biological_process |
GO:0030169 | Low-density lipoprotein particle binding | IDA IEA | molecular_function |
GO:0030194 | Positive regulation of blood coagulation | IEA | biological_process |
GO:0030301 | Cholesterol transport | IEA ISS | biological_process |
GO:0030666 | Endocytic vesicle membrane | TAS | cellular_component |
GO:0031092 | Platelet alpha granule membrane | TAS | cellular_component |
GO:0032735 | Positive regulation of interleukin-12 production | IEA | biological_process |
GO:0032755 | Positive regulation of interleukin-6 production | IEA | biological_process |
GO:0032760 | Positive regulation of tumor necrosis factor production | IEA | biological_process |
GO:0034134 | Toll-like receptor 2 signaling pathway | TAS | biological_process |
GO:0034142 | Toll-like receptor 4 signaling pathway | TAS | biological_process |
GO:0034381 | Plasma lipoprotein particle clearance | ISS | biological_process |
GO:0034383 | Low-density lipoprotein particle clearance | IEA IMP | biological_process |
GO:0035634 | Response to stilbenoid | IEA | biological_process |
GO:0038123 | Toll-like receptor TLR1:TLR2 signaling pathway | TAS | biological_process |
GO:0038124 | Toll-like receptor TLR6:TLR2 signaling pathway | TAS | biological_process |
GO:0042590 | Antigen processing and presentation of exogenous peptide antigen via MHC class I | TAS | biological_process |
GO:0042953 | Lipoprotein transport | IEA IMP TAS | biological_process |
GO:0042992 | Negative regulation of transcription factor import into nucleus | IEA | biological_process |
GO:0043123 | Positive regulation of I-kappaB kinase/NF-kappaB signaling | IEA | biological_process |
GO:0043277 | Apoptotic cell clearance | IEA | biological_process |
GO:0043410 | Positive regulation of MAPK cascade | IEA | biological_process |
GO:0044130 | Negative regulation of growth of symbiont in host | IEA | biological_process |
GO:0044255 | Cellular lipid metabolic process | TAS | biological_process |
GO:0044281 | Small molecule metabolic process | TAS | biological_process |
GO:0044539 | Long-chain fatty acid import | IDA | biological_process |
GO:0045087 | Innate immune response | TAS | biological_process |
GO:0045121 | Membrane raft | IEA | cellular_component |
GO:0045335 | Phagocytic vesicle | TAS | cellular_component |
GO:0050431 | Transforming growth factor beta binding | ISS | molecular_function |
GO:0050731 | Positive regulation of peptidyl-tyrosine phosphorylation | IEA | biological_process |
GO:0050830 | Defense response to Gram-positive bacterium | IEA | biological_process |
GO:0055096 | Low-density lipoprotein particle mediated signaling | IEA | biological_process |
GO:0060100 | Positive regulation of phagocytosis, engulfment | IEA | biological_process |
GO:0060907 | Positive regulation of macrophage cytokine production | IEA | biological_process |
GO:0070053 | Thrombospondin receptor activity | ISS | molecular_function |
GO:0070892 | Lipoteichoic acid receptor activity | IEA | molecular_function |
GO:0071221 | Cellular response to bacterial lipopeptide | IEA | biological_process |
GO:0071222 | Cellular response to lipopolysaccharide | IEA | biological_process |
GO:0071223 | Cellular response to lipoteichoic acid | IEA | biological_process |
GO:0071447 | Cellular response to hydroperoxide | IEA | biological_process |
GO:0071813 | Lipoprotein particle binding | IDA | molecular_function |
GO:2000121 | Regulation of removal of superoxide radicals | IEA | biological_process |
GO:2000334 | Positive regulation of blood microparticle formation | IEA | biological_process |
GO:2000379 | Positive regulation of reactive oxygen species metabolic process | IEA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0014170966 | 0.9264096577 | 0.1010823848 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.3894845839 |
GSE13712_SHEAR | Up | 0.0972516545 |
GSE13712_STATIC | Down | -0.5690814513 |
GSE19018 | Up | 0.0768908356 |
GSE19899_A1 | Up | 0.1220949295 |
GSE19899_A2 | Up | 1.6920541809 |
PubMed_21979375_A1 | Up | 1.4172813158 |
PubMed_21979375_A2 | Up | 1.8053474014 |
GSE35957 | Up | 1.6478876325 |
GSE36640 | Up | 1.4322422100 |
GSE54402 | Up | 1.3144084585 |
GSE9593 | Down | -0.6882647288 |
GSE43922 | Up | 1.5190854072 |
GSE24585 | Up | 0.2156769659 |
GSE37065 | Up | 0.1964770371 |
GSE28863_A1 | Down | -0.3928396666 |
GSE28863_A2 | Up | 0.6725340253 |
GSE28863_A3 | Down | -0.0038684533 |
GSE28863_A4 | Up | 0.0178005750 |
GSE48662 | Up | 0.1577377261 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-335-5p | MIMAT0000765 | MIRT018933 | Microarray | Functional MTI (Weak) | 18185580 |
hsa-miR-155-5p | MIMAT0000646 | MIRT021050 | Proteomics;Other | Functional MTI (Weak) | 20584899 |
hsa-miR-26b-5p | MIMAT0000083 | MIRT030109 | Microarray | Functional MTI (Weak) | 19088304 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 7 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
23119050 | Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process |
23119050 | We aimed to analyse the role of p38-MAPK and HIF-1 in the transcriptional regulation of CD36, a class B scavenger receptor, and its ligand thrombospondin (TSP-1) in macrophages and to evaluate the involvement of this pathway in phagocytosis of apoptotic neutrophils |
23119050 | We have also assessed HIF-1alpha, p38-MAPK and CD36 immunostaining in the mucosa of patients with inflammatory bowel disease |
23119050 | Results show that hypoxia increases neutrophil phagocytosis by macrophages and induces the expression of CD36 and TSP-1 |
23119050 | Addition of a p38-MAPK inhibitor significantly reduced the increase in CD36 and TSP-1 expression provoked by hypoxia and decreased HIF-1alpha stabilization in macrophages |
23119050 | Transient transfection of macrophages with a miHIF-1alpha-targeting vector blocked the increase in mRNA expression of CD36 and TSP-1 during hypoxia and reduced phagocytosis, thus highlighting a role for the transcriptional activity of HIF-1 |
23119050 | CD36 and TSP-1 were necessary for the phagocytosis of neutrophils induced by hypoxic macrophages, since functional blockade of these proteins undermined this process |
23119050 | Immunohistochemical studies revealed CD36, HIF-1alpha and p38-MAPK expression in the mucosa of patients with inflammatory bowel disease |
23119050 | A positive and significant correlation between HIF-1alpha and CD36 expression and CD36 and p38-MAPK expression was observed in cells of the lamina propria of the damaged mucosa |
23119050 | Our results demonstrate a HIF-1-dependent up-regulation of CD36 and TSP-1 that mediates the increased phagocytosis of neutrophils by macrophages during hypoxia |
23119050 | Moreover, they suggest that CD36 expression in the damaged mucosa of patients with inflammatory bowel disease depends on p38-MAPK and HIF-1 activity |
19064796 | CD36 is a well-recognized integral microglia/macrophage cell membrane protein known to mediate phagocytosis of damaged, apoptotic, or senescent cells, including erythrocytes |
19064796 | CD36 and catalase expression are regulated by peroxisome proliferator activated receptor-gamma agonists (eg, rosiglitazone) |
19064796 | We demonstrate that peroxisome proliferator activated receptor-gamma agonist-induced upregulation of CD36 in macrophages enhances the ability of microglia to phagocytose red blood cells (in vitro assay), helps to improve hematoma resolution, and reduces ICH-induced deficit in a mouse model of ICH |
18220826 | Previous experiments showed the involvement of phosphatidylserine and CD36 in the recognition of effete cell |
17407326 | Conformation of an endogenous ligand in a membrane bilayer for the macrophage scavenger receptor CD36 |
17407326 | A structurally conserved family of oxidized phospholipids that serve as endogenous high-affinity ligands for the macrophage scavenger receptor CD36 (oxPC(CD36)) was recently identified |
17407326 | The molecular model reveals a unique conformation for oxPC(CD36) within bilayers whereby the distal end of the sn-2 acyl chain harboring the structurally conserved CD36 recognition motif protrudes into the aqueous phase |
17407326 | The remarkable conformation elucidated for oxPC(CD36) produces a surface accessible phagocytic "eat me signal" to facilitate senescent cell and oxidized lipoprotein recognition by the scavenger receptor CD36 as part of its immune surveillance function |
10709907 | PS-liposome and ox-LDL bind to different sites of the immunodominant domain (#155-183) of CD36: a study with GS95, a new anti-CD36 monoclonal antibody |
10709907 | CD36, a multifunctional adhesive receptor on a variety of cells such as monocytes and platelets, has been implicated in clearance of modified LDL and in the removal of apoptotic or senescent cells |
10709907 | We determined the binding site of phosphatidylserine (PS)-liposome on CD36 by flow cytometric analysis of competitive bindings between phospholipid-liposomes or synthetic CD36 peptides and FITC-labeled anti-CD36 antibodies (GS95, OKM5, and FA6-152) |
10709907 | The epitope of GS95 was mapped to the amino acid sequence #162-183 of CD36 that was partially overlapped with, but distinct from, #155-183, which has been reported as the epitopes of two commercially available antibodies, OKM5 and FA6-152 |
10709907 | Oxidized-LDL dose-dependently inhibited bindings of both GS95 and OKM5 antibodies to platelet CD36, while PS-liposome inhibited the binding of GS95 but not OKM5 or FA6-152 |
10709907 | These results indicate that the binding site of PS-liposome on platelet CD36 is not identical to that of oxidized-LDL and may be located in the amino acid sequence #162-183 |
8780395 | Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response |
8780395 | Ingestion of apoptotic neutrophils by human monocyte-derived macrophages (M phi s) was found to be mediated by adhesive interactions between thrombospondin and the M phi alpha v beta 3 vitronectin receptor integrin and M phi CD36 |
8780395 | In this study, we found that M phi ingestion of apoptotic eosinophils was specifically inhibited by monoclonal antibodies to M phi alpha v beta 3, CD36, and thrombospondin and by other inhibitors of this recognition mechanism including RGD peptide and amino sugars |
8780395 | The data indicate that the nonphlogistic alpha v beta 3/CD36/thrombospondin macrophage recognition mechanism is available for clearance of intact senescent eosinophils undergoing apoptosis |
7541795 | The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids |
7541795 | Using both direct binding and ligand competition assays in transfected cells, we have found that two class B scavenger receptors, SR-BI and CD36, can tightly bind PS and phosphatidylinositol (PI)-containing liposomes (Kd for PS liposome binding to SR-BI is approximately 15 micrograms phospholipid/ml or 0 |
Entries Per Page
Displaying Page of